BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7954254)

  • 21. Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations.
    Yamazaki K; Tajima Y; Makino R; Nishino N; Aoki S; Kato M; Sakamoto M; Morohara K; Kaetsu T; Kusano M
    World J Gastroenterol; 2006 Jun; 12(24):3803-9. PubMed ID: 16804962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
    Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
    Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early changes in carcinogenesis of colorectal adenomas.
    Toru S; Bilezikçi B
    West Indian Med J; 2012 Jan; 61(1):10-6. PubMed ID: 22808560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunohistochemical expression of bcl-2, bcl-xL, bax, p53 proteins in gastric adenoma and adenocarcinoma].
    Lee DS; Kang SB; Baek JT; Nam SW; Lee KM; Ahn BM; Lee EH; Han SW; Chung IS
    Korean J Gastroenterol; 2005 Jun; 45(6):394-400. PubMed ID: 15973073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features and immunoexpression of p53, MIB-1 and proliferating cell nuclear antigen in adrenal neoplasms.
    Martins AC; Cologna AJ; Tucci S; Suaid HJ; Falconi RA
    J Urol; 2005 Jun; 173(6):2138-42. PubMed ID: 15879867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural history of precursor lesions to gastric carcinoma: growth factors and oncogenes in the metaplasia-dysplasia-carcinoma sequence.
    Filipe MI
    Eur J Cancer Prev; 1994 Dec; 3 Suppl 2():19-23. PubMed ID: 7735041
    [No Abstract]   [Full Text] [Related]  

  • 27. [Expression of c-erbB-2 and c-met proteins in gastric adenoma and adenocarcinoma].
    Lee SW; Kang SB; Kim YS; Nam SW; Lee DS; Lee HK; Han SW
    Korean J Gastroenterol; 2007 Mar; 49(3):152-7. PubMed ID: 18172343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater.
    Ajiki T; Kamigaki T; Hasegawa Y; Fujino Y; Suzuki Y; Takeyama Y; Ku Y; Kuroda Y
    Hepatogastroenterology; 2001; 48(41):1266-70. PubMed ID: 11677943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical analysis of pyloric gland adenomas using a series of Mucin 2, Mucin 5AC, Mucin 6, CD10, Ki67 and p53.
    Vieth M; Kushima R; Mukaisho K; Sakai R; Kasami T; Hattori T
    Virchows Arch; 2010 Nov; 457(5):529-36. PubMed ID: 20827489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
    Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
    J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of expression of proliferating cell nuclear antigen and E-cadherin in gastric carcinoma.
    Hu L; Li HL; Li WF; Chen JM; Yang JT; Gu JJ; Xin L
    World J Gastroenterol; 2017 May; 23(20):3721-3729. PubMed ID: 28611525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. bcl-2 protein expression in gastric remnant mucosa and gastric cancer 15 or more years after partial gastrectomy.
    Clarke MR; Safatle-Ribeiro AV; Ribeiro U; Sakai P; Reynolds JC
    Mod Pathol; 1997 Oct; 10(10):1021-7. PubMed ID: 9346182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Bcl-2 and p53 in the colorectal adenoma-carcinoma sequence.
    Hao XP; Ilyas M; Talbot IC
    Pathobiology; 1997; 65(3):140-5. PubMed ID: 9309780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation of DNA ploidy, c-erbB-2 protein tissue status, level of PCNA expression and clinical outcome in gastric carcinomas].
    Takamura H; Yonemura Y; Hirono Y; Ninomiya I; Sahara H; Tsugawa K; Matsumoto H; Sugiyama K; Fujimura T; Nishimura G
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):788-95. PubMed ID: 8098198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Villous tumor of the stomach associated with adenocarcinomas--a histochemical study of mucosubstances.
    Inaba S; Tanaka T; Okanoue T; Kodama T; Maruyama K; Itoi H; Kobayashi M; Takino T; Oka T
    Jpn J Clin Oncol; 1984 Dec; 14(4):691-8. PubMed ID: 6520973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach.
    Kim HS; Hong EK; Park SY; Kim WH; Lee HS
    Anticancer Res; 2003; 23(3C):2863-8. PubMed ID: 12926124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of immunohistochemistry in histopathological diagnostics of clinically "silent" incidentally detected adrenal masses.
    Babinska A; Sworczak K; Wisniewski P; Nałecz A; Jaskiewicz K
    Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):246-51. PubMed ID: 18393131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.
    Matsubayashi S; Yoshihara T
    Eur Arch Otorhinolaryngol; 2007 Jul; 264(7):789-95. PubMed ID: 17310348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Bcl-2 and c-ErbB-2 in colorectal neoplasia.
    Dursun A; Poyraz A; Süer O ; Sezer C; Akyol G
    Pathol Oncol Res; 2001; 7(1):24-7. PubMed ID: 11349216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.